Center for Scientific Review; Notice of Meeting, 14174 [2023-04622]

Download as PDF 14174 Federal Register / Vol. 88, No. 44 / Tuesday, March 7, 2023 / Notices studies and data that the GDC supports and allows for a standard mechanism for the GDC to assess incoming data submission requests. OMB approval is requested for 3 years. There are no costs to respondents other than their time. The total estimated annualized burden hours are 50 hours. ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Type of respondent Average time per response (in hours) Total annual burden hour Investigator ...................................................................................................... 200 1 15/60 50 Total .......................................................................................................... ........................ 200 ........................ 50 Dated: March 2, 2023. Diane Kreinbrink, Project Clearance Liaison, National Cancer Institute, National Institutes of Health. [FR Doc. 2023–04628 Filed 3–6–23; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the Center for Scientific Review Advisory Council. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should register at: https://public.csr.nih.gov/ AboutCSR/Organization/ CSRAdvisoryCouncil/Registration. The meeting can be viewed remotely via the NIH Videocasting website: https://videocast.nih.gov/watch=49156. ddrumheller on DSK120RN23PROD with NOTICES1 Number of responses per respondent Name of Committee: Center for Scientific Review Advisory Council. Date: March 27, 2023. Time: 10:00 a.m. to 3:00 p.m. Agenda: Provide advice to the Director, Center for Scientific Review (CSR), on matters related to planning, execution, conduct, support, review, evaluation, and receipt and referral of grant applications at CSR. Place: National Institutes of Health, 6701 Rockledge Drive, Conference Room 160A, Bethesda, MD 20892. Contact Person: Bruce Reed, Ph.D., Deputy Director, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594–9159, reedbr@mail.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the VerDate Sep<11>2014 19:49 Mar 06, 2023 Jkt 259001 name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has stringent procedures for entrance into NIH federal property. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. Additional Health and Safety Guidance: Before attending a meeting at an NIH facility, it is important that visitors review the NIH COVID–19 Safety Plan at https:// ors.od.nih.gov/sr/dohs/safety/NIH-covid-19safety-plan/Pages/default.aspx for information about requirements and procedures for entering NIH facilities, especially when the COVID–19 community level is medium. If the COVID–19 level is high, the meeting will be held virtually. In addition, the Safer Federal Workforce website has FAQs for visitors at https:// www.saferfederalworkforce.gov/faq/visitors/. Please note that if an individual has a COVID–19 diagnosis within 10 days of the meeting, that person must attend virtually. (For more information please read NIH’s Requirements for Persons after Exposure at https://ors.od.nih.gov/sr/dohs/safety/NIHcovid-19-safety-plan/COVID-assessmenttesting/Pages/persons-after-exposure.aspx and What Happens When Someone Tests Positive at https://ors.od.nih.gov/sr/dohs/ safety/NIH-covid-19-safety-plan/COVIDassessment-testing/Pages/test-positive.aspx.) Anyone from the public can attend the meeting virtually via the NIH Videocasting website (https://videocast.nih.gov). Please continue checking these websites, in addition to the committee website listed below, for the most up-to-date guidance as the meeting date approaches. Information is also available on the Institute’s/Center’s home page: https:// public.csr.nih.gov/AboutCSR/Organization/ CSRAdvisoryCouncil, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) PO 00000 Frm 00061 Fmt 4703 Sfmt 4703 Dated: March 1, 2023. Tyeshia M. Roberson-Curtis, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–04622 Filed 3–6–23; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF THE INTERIOR U.S. Geological Survey [GX23EE000101100] Public Meeting of the National Geospatial Advisory Committee Department of the Interior. Notice of public meeting. AGENCY: ACTION: In accordance with the Federal Advisory Committee Act (FACA) of 1972, the U.S. Geological Survey (USGS) is publishing this notice to announce that a Federal Advisory Committee meeting of the National Geospatial Advisory Committee (NGAC) will take place. DATES: The webinar meeting will be held on Tuesday, April 11, 2023, from 1 p.m. to 5 p.m. and on Wednesday, April 12, 2023, from 1 p.m. to 5 p.m. (Eastern Standard Time). ADDRESSES: The meeting will be held on-line and via teleconference. Instructions for accessing the meeting will be posted at www.fgdc.gov/ngac. Comments can be sent by email to gsfaca@usgs.gov. FOR FURTHER INFORMATION CONTACT: Mr. John Mahoney, Federal Geographic Data Committee (FGDC), USGS, by mail at 909 First Avenue, Room 703, Seattle, WA 98104; or by email at jmahoney@ usgs.gov; or by telephone at (206) 375– 2565. SUPPLEMENTARY INFORMATION: This meeting is being held under the provisions of the FACA of 1972 (5 U.S.C., Appendix 10), the Government in the Sunshine Act of 1976 (5 U.S.C. 552B, as amended), and 41 CFR 102– 3.140 and 102–3.150. SUMMARY: E:\FR\FM\07MRN1.SGM 07MRN1

Agencies

[Federal Register Volume 88, Number 44 (Tuesday, March 7, 2023)]
[Notices]
[Page 14174]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-04622]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the Center for 
Scientific Review Advisory Council.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should register at: https://public.csr.nih.gov/AboutCSR/Organization/CSRAdvisoryCouncil/Registration.
    The meeting can be viewed remotely via the NIH Videocasting 
website: https://videocast.nih.gov/watch=49156.

    Name of Committee: Center for Scientific Review Advisory 
Council.
    Date: March 27, 2023.
    Time: 10:00 a.m. to 3:00 p.m.
    Agenda: Provide advice to the Director, Center for Scientific 
Review (CSR), on matters related to planning, execution, conduct, 
support, review, evaluation, and receipt and referral of grant 
applications at CSR.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Conference Room 160A, Bethesda, MD 20892.
    Contact Person: Bruce Reed, Ph.D., Deputy Director, Center for 
Scientific Review, National Institutes of Health, 6701 Rockledge 
Drive, Bethesda, MD 20892, (301) 594-9159, [email protected].

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has stringent procedures for 
entrance into NIH federal property. Visitors will be asked to show 
one form of identification (for example, a government-issued photo 
ID, driver's license, or passport) and to state the purpose of their 
visit.
    Additional Health and Safety Guidance: Before attending a 
meeting at an NIH facility, it is important that visitors review the 
NIH COVID-19 Safety Plan at https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/Pages/default.aspx for information about 
requirements and procedures for entering NIH facilities, especially 
when the COVID-19 community level is medium. If the COVID-19 level 
is high, the meeting will be held virtually. In addition, the Safer 
Federal Workforce website has FAQs for visitors at https://www.saferfederalworkforce.gov/faq/visitors/. Please note that if an 
individual has a COVID-19 diagnosis within 10 days of the meeting, 
that person must attend virtually. (For more information please read 
NIH's Requirements for Persons after Exposure at https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/COVID-assessment-testing/Pages/persons-after-exposure.aspx and What 
Happens When Someone Tests Positive at https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/COVID-assessment-testing/Pages/test-positive.aspx.) Anyone from the public can attend the meeting 
virtually via the NIH Videocasting website (https://videocast.nih.gov). Please continue checking these websites, in 
addition to the committee website listed below, for the most up-to-
date guidance as the meeting date approaches.
    Information is also available on the Institute's/Center's home 
page: https://public.csr.nih.gov/AboutCSR/Organization/CSRAdvisoryCouncil, where an agenda and any additional information 
for the meeting will be posted when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: March 1, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-04622 Filed 3-6-23; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.